These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3940235)

  • 1. Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers.
    Andriulli A; Gindro T; Piantino P; Farini R; Cavallini G; Piazzi L; Naccarato R; Dobrilla G; Verme G; Scuro LA
    Digestion; 1986; 33(1):26-33. PubMed ID: 3940235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases.
    Kuusela P; Haglund C; Roberts PJ; Jalanko H
    Br J Cancer; 1987 Jun; 55(6):673-6. PubMed ID: 2441731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
    Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
    Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
    Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer.
    Schneider J; Schulze G
    Anticancer Res; 2003; 23(6D):5089-93. PubMed ID: 14981971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies.
    Heptner G; Domschke S; Domschke W
    Scand J Gastroenterol; 1989 Aug; 24(6):745-50. PubMed ID: 2814339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tag 72: a new tumor-associated antigen identified by a monoclonal antibody].
    Piantino P; Fusaro A; Daziano E; Polloni R; Mosso R; Cacace G
    Minerva Med; 1990 Nov; 81(11):765-7. PubMed ID: 2255410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of carcinoembryonic antigen and related antigens in sera of patients with gastrointestinal tumors using monoclonal antibodies in double-determinant radioimmunoassays.
    Herlyn M; Blaszczyk M; Sears HF; Verrill H; Lindgren J; Colcher D; Steplewski Z; Schlom J; Koprowski H
    Hybridoma; 1983; 2(3):329-39. PubMed ID: 6205981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer.
    Kornek G; Depisch D; Temsch EM; Scheithauer W
    J Cancer Res Clin Oncol; 1991; 117(5):493-6. PubMed ID: 1890143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies.
    Kornek GV; Depisch D; Rosen HR; Temsch EM; Scheithauer W
    J Cancer Res Clin Oncol; 1992; 118(4):318-20. PubMed ID: 1374412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
    Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma.
    Satake K; Kanazawa G; Kho I; Chung YS; Umeyama K
    J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
    Staab HJ; Hornung A; Anderer FA; Kieninger G
    Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human alveolar macrophage-56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas.
    Fowler LJ; Maygarden SJ; Novotny DB
    Hum Pathol; 1994 Jul; 25(7):666-70. PubMed ID: 8026826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
    Czakó L; Takács T; Babarczy E; Dux L; Lonovics J
    Orv Hetil; 1997 Nov; 138(47):2981-5. PubMed ID: 9432648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies.
    Yoshikawa T; Nishida K; Tanigawa M; Fukumoto K; Kondo M
    Digestion; 1985; 31(2-3):67-76. PubMed ID: 2581838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of a new tumor serologic marker, CA 19-9: comparison with CEA.
    Civardi G; Cerri L; Cavanna L; Fornari F; Di Stasi M; Binelli F
    Tumori; 1986 Dec; 72(6):621-4. PubMed ID: 3468674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.